Cost-utility Analysis of Screening for Diabetic Retinopathy in Japan: A Probabilistic Markov Modeling Study

REFERENCES

• Fenwick E, Rees G, Pesudovs K, et al. Social and emotional impact of diabetic retinopathy: a review. Clin Experiment Ophthalmol 2012;40:27–38
   PubMed Web of Science ®Google Scholar
• Fenwick EK, Pesudovs K, Rees G, et al. The impact of diabetic retinopathy: understanding the patient’s perspective. Br J Ophthalmol 2011;95:774–782
   PubMed Web of Science ®Google Scholar
• Yau JW, Rogers SL, Kawasaki R, et al. Global prevalence and major risk factors of diabetic retinopathy. Diabetes Care 2012;35:556–564
   PubMed Web of Science ®Google Scholar
• Pershing S, Enns EA, Matesic B, Owens DK, Goldhaber-Fiebert JD. Cost-effectiveness of treatment of diabetic macular edema. Ann Internal Med 2014;160:18–29
   PubMed Web of Science ®Google Scholar
• Kinukawa J, Shimura M, Harata N, Tamai M. Gliclazide attenuates the intracellular Ca2+ changes induced in vitro by ischemia in the retinal slices of rats with streptozotocin-induced diabetes. Curr Eye Res 2005;30:789–798
   PubMed Web of Science ®Google Scholar
• Bragge P, Gruen RL, Chau M, et al. Screening for presence or absence of diabetic retinopathy: a meta-analysis. Arch Ophthalmol 2011;129:435–444
   PubMed Web of Science ®Google Scholar
• Ministry of Health, Labour and Welfare, Japan. The National Health and Nutrition Survey in Japan, 2009. 2011
   Google Scholar
• Oizumi T. [Epidemiologic investigation on the incidence of diabetes mellitus from impaired glucose tolerance in population based study]. Nihon Rinsho 2005;63(Suppl. 2):73–77
   PubMedGoogle Scholar
• Miyazaki M, Kubo M, Kiyohara Y, et al. Comparison of diagnostic methods for diabetes mellitus based on prevalence of retinopathy in a Japanese population: the Hisayama Study. Diabetologia 2004;47:1411–1415
   PubMed Web of Science ®Google Scholar
• Ministry of Health, Labour and Welfare, Japan. Implementation rate of specific health checkup and specific counseling guidance for 2009 in Japan; 2011. Accessed July 30, 2013 from: www.mhlw.go.jp/bunya/shakaihosho/iryouseido01/info03_h21.html
   Google Scholar
• Ministry of Health Labour and Welfare, Japan. National Health and Nutrition Survey for 2002 in Japan; 2002. Accessed July 30, 2013 from: www.mhlw.go.jp/toukei/kouhyo/indexkk_4_2.html
   Google Scholar
• OECD. Health at a Glance 2007: OECD Indicators. Paris: OECD Publishing. 2007
   Google Scholar
• Holden BA, Fricke TR, Ho SM, et al. Global vision impairment due to uncorrected presbyopia. Arch Ophthalmol 2008;126:1731–1739
   PubMed Web of Science ®Google Scholar
• Funatsu H. Status of ophthalmological examination in diabetics. [In Japanese]. Folia Ophthalmologica Japonica 1997;48:7–13
   Google Scholar
• Nguyen QD, Brown DM, Marcus DM, et al. Ranibizumab for diabetic macular edema: results from 2 phase III randomized trials: RISE and RIDE. Ophthalmology 2012;119:789–801
   PubMed Web of Science ®Google Scholar
• Mitchell P, Bandello F, Schmidt-Erfurth U, et al. The RESTORE study: ranibizumab monotherapy or combined with laser versus laser monotherapy for diabetic macular edema. Ophthalmology 2011;118:615–625
   PubMed Web of Science ®Google Scholar
• Yamamoto T, Hitani K, Tsukahara I, et al. Early postoperative retinal thickness changes and complications after vitrectomy for diabetic macular edema. Am J Ophthalmol 2003;135:14–19
   PubMed Web of Science ®Google Scholar
• Sakamoto T, Hida T, Tano Y, et al. [Survey of triamcinolone acetonide for ocular diseases in Japan]. Nihon Ganka Gakkai Zasshi 2007;111:936–945
   PubMedGoogle Scholar
• Yamakiri K, Sakamoto T, Noda Y, et al. Reduced incidence of intraoperative complications in a multicenter controlled clinical trial of triamcinolone in vitrectomy. Ophthalmology 2007;114:289–296
   PubMed Web of Science ®Google Scholar
• Chew EY, Ferris FL III, Csaky KG, et al. The long-term effects of laser photocoagulation treatment in patients with diabetic retinopathy: the early treatment diabetic retinopathy follow-up study. Ophthalmology 2003;110:1683–1689
   PubMed Web of Science ®Google Scholar
• Nakamura S, Funatsu H, Yagi T, et al. Five-year outcome of retinal photocoagulation in patients with diabetic retinopathy. [In Japanese]. Folia Ophthalmol Jpn 2003;54:329–333
   Google Scholar
• Yoshida S, Matsumoto T, Nabeshima T, et al. A two-year review of vitreous surgery for proliferative diabetic retinopathy. Jpn J Clin Ophthalmol 2010;64:1911–1915
   Google Scholar
• Hiratsuka Y, Yamada M, Murakami A, et al. Cost-effectiveness of cataract surgery in Japan. Jpn J Ophthalmol 2011;55:333–342
   PubMed Web of Science ®Google Scholar
• Brown GC. Vision and quality-of-life. Trans Am Ophthalmol Soc 1999;97:473–511
   PubMedGoogle Scholar
• Mulvaney-Day NE, Horvitz-Lennon M, Chen CN, et al. Valuing health in a racially and ethnically diverse community sample: an analysis using the valuation metrics of money and time. Qual Life Res 2010;19:1529–1540
   PubMed Web of Science ®Google Scholar
• Szabo SM, Beusterien KM, Pleil AM, et al. Patient preferences for diabetic retinopathy health states. Invest Ophthalmol Vis Sci 2010;51:3387–3394
   PubMed Web of Science ®Google Scholar
• Briggs AH, Gray AM. Handling uncertainty in economic evaluations of healthcare interventions. BMJ 1999;319:635–638
   PubMed Web of Science ®Google Scholar
• Briggs AH, Gray AM. Handling uncertainty when performing economic evaluation of healthcare interventions. Health Technol Assess 1999;3:1–134
   PubMedGoogle Scholar
• Ministry of Health, Labour and Welfare, Japan. Survey of medical care activities in public health insurance. 2010
   Google Scholar
• Shiroiwa T, Sung YK, Fukuda T, et al. International survey on willingness-to-pay (WTP) for one additional QALY gained: what is the threshold of cost effectiveness? Health Econ 2010;19:422–437
   PubMed Web of Science ®Google Scholar
• A basic direction for comprehensive implementation of national health promotion 2012. Accessed June 4, 2014 from: http://www.mhlw.go.jp/file/06-Seisakujouhou-10900000-Kenkoukyoku/0000047330.pdf
   Google Scholar
• Vijan S, Hofer TP, Hayward RA. Cost-utility analysis of screening intervals for diabetic retinopathy in patients with type 2 diabetes mellitus. JAMA 2000;283:889–896
   PubMed Web of Science ®Google Scholar
• Jones S, Edwards RT. Diabetic retinopathy screening: a systematic review of the economic evidence. Diabet Med 2010;27:249–256
   PubMed Web of Science ®Google Scholar
• Furlong WJ, Feeny DH, Torrance GW, Barr RD. The Health Utilities Index (HUI) system for assessing health-related quality of life in clinical studies. Ann Med 2001;33:375–384
   PubMed Web of Science ®Google Scholar
• Brown MM, Brown GC, Sharma S. Evidence-based to value-based medicine. Chicago: American Medical Association Press; 2005
   Google Scholar
• Sharma S, Brown GC, Brown MM, et al. Validity of the time trade-off and standard gamble methods of utility assessment in retinal patients. Br J Ophthalmol 2002;86:493–496
   PubMed Web of Science ®Google Scholar